Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 06, 2021

SELL
$2.7 - $3.81 $67,481 - $95,223
-24,993 Closed
0 $0
Q1 2021

May 03, 2021

SELL
$3.02 - $5.16 $54,360 - $92,880
-18,000 Reduced 41.87%
24,993 $83,000
Q3 2020

Nov 12, 2020

BUY
$3.01 - $3.88 $129,408 - $166,812
42,993 New
42,993 $135,000

Others Institutions Holding MBIO

About MUSTANG BIO, INC.


  • Ticker MBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,222,000
  • Market Cap $22.1M
  • Description
  • Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...
More about MBIO
Track This Portfolio

Track Acg Wealth Portfolio

Follow Acg Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acg Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Acg Wealth with notifications on news.